Caprock Group’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Buy
+6,186
New +$224K 0.01% 525

Other funds holding ROIV

Caprock Group's ROIV Position: Q3 2026 in Review

Caprock Group opened a new position in Roivant Sciences (ROIV) in Q3 2026: 6,186 shares worth $226K. The stake represents 0.01% of the portfolio and ranks #525 among its holdings.

522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Caprock Group held 6,186 shares of Roivant Sciences worth $226K as of Q3 2026.
  • Roivant Sciences was a new Caprock Group position in Q3 2026.
  • Roivant Sciences made up 0.01% of Caprock Group's portfolio in Q3 2026, its #525 holding.
  • 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Caprock Group's 13F filing for Q3 2026, filed 17 Nov 2026.